Premas Biotech and Oramed announce oral COVID-19 vaccine candidate that produces antibodies after a single dose

Must Read

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. …

Latest News

BGN works with AGO to curb budget violations in free meals program

Indonesia’s National Nutrition Agency has partnered with prosecutors to strengthen oversight of funds used in the ...

More Articles Like This